Should the Faecal Microbiota Composition Be Determined to Certify a Faecal Donor?|https://dx.doi.org/10.3390/diagnostics14232635
Impact of the Number of Patellar Dislocations on Outcomes of Isolated Medial Patellofemoral Ligament Reconstruction.|https://dx.doi.org/10.1177/23259671241274769
Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 months.|https://dx.doi.org/10.1016/j.dld.2024.11.025
Screening novel antiviral compounds to treat Clostridioides difficile infections.|https://dx.doi.org/10.1371/journal.pone.0309624
Retraction: Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.|https://dx.doi.org/10.1371/journal.pone.0316040
Clinical significance of toxin EIA positivity in patients with suspected Clostridioides difficile infection: systematic review and meta-analysis.|https://dx.doi.org/10.1128/jcm.00977-24
Impact of type 2 diabetes mellitus on mortality and recurrence of clostridioides difficile infection.|https://dx.doi.org/10.1080/21548331.2024.2440305
The presence of Clostridioides difficile in faeces before and after faecal microbiota transplantation and its relation with recurrent C. difficile infection and the gut microbiota in a Dutch cohort.|https://dx.doi.org/10.1016/j.cmi.2024.12.003
Partial biochemical response of adrenal artery embolization for pheochromocytoma: A case report and review of the literature.|https://dx.doi.org/10.1016/j.radcr.2024.10.107
Loop Ileostomy With Colonic Lavage: Case Report of an Alternative to Total Colectomy in the Setting of Fulminant Clostridium difficile Colitis.|https://dx.doi.org/10.7759/cureus.73141
FMT Restores Colonic Protein Biosynthesis and Cell Proliferation in Patients with Recurrent Clostridioides difficile Disease.|https://dx.doi.org/10.1101/2024.11.28.24318101
Case report: Fecal microbiota transplant for Clostridium difficile infection in a pregnant patient with acute severe ulcerative colitis.|https://dx.doi.org/10.3389/fimmu.2024.1417003
Assessing live microbial therapeutic transmission.|https://dx.doi.org/10.1080/19490976.2024.2447836
Clostridioides difficile Infections and Factors Associated with Recurrence.|https://dx.doi.org/10.36519/idcm.2024.380
Predicting recurrent Clostridioides difficile infection by assessing antimicrobial treatment based on days of antibiotic spectrum coverage and ATLAS scores.|https://dx.doi.org/10.1016/j.jiac.2024.102603
Allogenic faecal microbiota transplantation for antibiotic-associated diarrhoea in critically ill patients (FEBATRICE)-Study protocol for a multi-centre randomised controlled trial (phase II).|https://dx.doi.org/10.1371/journal.pone.0310180
Fecal microbiota transplantation for glaucoma; a potential emerging treatment strategy.|https://dx.doi.org/10.1016/j.crmicr.2024.100314
Preventing Clostridioides difficile Infection Recurrence.|https://dx.doi.org/10.1097/01.NAJ.0001094820.16262.70
Clostridioides difficile Infection and Testing Rates in South Africa: A multicentre study, 2017-2020.|https://dx.doi.org/10.1016/j.anaerobe.2024.102937
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection.|https://dx.doi.org/10.1038/s41591-024-03337-4
